Abstract

BackgroundSatellite cells (SCs) are indispensable for muscle regeneration and repair; however, due to low frequency in primary muscle and loss of engraftment potential after ex vivo expansion, their use in cell therapy is currently unfeasible. To date, an alternative to this limitation has been the transplantation of SC-derived myogenic progenitor cells (MPCs), although these do not hold the same attractive properties of stem cells, such as self-renewal and long-term regenerative potential.MethodsWe develop a method to expand wild-type and dystrophic fresh isolated satellite cells using transient expression of Pax3. This approach can be combined with genetic correction of dystrophic satellite cells and utilized to promote muscle regeneration when transplanted into dystrophic mice.ResultsHere, we show that SCs from wild-type and dystrophic mice can be expanded in culture through transient expression of Pax3, and these expanded activated SCs can regenerate the muscle. We test this approach in a gene therapy model by correcting dystrophic SCs from a mouse lacking dystrophin using a Sleeping Beauty transposon carrying the human μDYSTROPHIN gene. Transplantation of these expanded corrected cells into immune-deficient, dystrophin-deficient mice generated large numbers of dystrophin-expressing myofibers and improved contractile strength. Importantly, in vitro expanded SCs engrafted the SC compartment and could regenerate muscle after secondary injury.ConclusionThese results demonstrate that Pax3 is able to promote the ex vivo expansion of SCs while maintaining their stem cell regenerative properties.Electronic supplementary materialThe online version of this article (doi:10.1186/s13395-015-0061-7) contains supplementary material, which is available to authorized users.

Highlights

  • Satellite cells (SCs) are indispensable for muscle regeneration and repair; due to low frequency in primary muscle and loss of engraftment potential after ex vivo expansion, their use in cell therapy is currently unfeasible

  • Sleeping Beauty system and generation of corrected μ -dystrophinΔR4–23/ΔCT (μDYS)-Pax3-induced cells We developed a bicistronic T2-inverted terminal repeat transposon (Tn) vector carrying an 11.3-kb engineered transgene containing the skeletal α-actin promoter that drives μDYS and a ubiquitin promoter that drives a green fluorescent protein (GFP)-2ANeo reporter gene, which allows for the selection of μDYS-corrected mdx-Pax3-induced cells

  • Derivation and ex vivo expansion of satellite cells using Pax3 To determine whether SCs maintained engraftment potential when expanded ex vivo using conditional expression of Pax3, we followed the strategy summarized in Fig. 1a, in which SCs from the transgenic Pax7-ZsGreen reporter mouse [27] were (I) purified by flow cytometry, (II) genetically modified with a lentiviral vector encoding a doxycycline-inducible Pax3 transgene, (III) expanded ex vivo in the presence of doxycycline, and (IV) transplanted into immune-deficient, dystrophin-deficient NSG-mdx4Cv [31] mice

Read more

Summary

Introduction

Satellite cells (SCs) are indispensable for muscle regeneration and repair; due to low frequency in primary muscle and loss of engraftment potential after ex vivo expansion, their use in cell therapy is currently unfeasible. An alternative to this limitation has been the transplantation of SC-derived myogenic progenitor cells (MPCs), these do not hold the same attractive properties of stem cells, such as selfrenewal and long-term regenerative potential. Loss of regeneration is thought to be due to exhaustion or impairment of satellite cells. These are resident adult muscle stem cells located underneath the basal lamina [4] that actively. An essential requirement for muscle cell-based therapies is the development of an approach that enables the ex vivo expansion of satellite cells while maintaining their “stemness” and regeneration potential

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call